Cervical lymphadenopathy presents a shared anatomic challenge for clinicians, yet it serves as the divergent starting point ...
Hosted on MSN

What Is Stage 3 Lymphoma?

Stage 3 lymphoma is a type of cancer that starts in a type of white blood cell called lymphocytes and has spread to lymph nodes on both sides of the diaphragm. It may also be in other organs near ...
What Is Marginal Zone Lymphoma? Marginal zone lymphoma (MZL) isn’t one disease. It’s a group of rare, slow-growing blood cancers. They’re known as non-Hodgkin lymphomas because they start in your ...
It develops from the abnormal multiplication of T cells, or T-lymphocytes, a type of white blood cell essential for immune system function. The specific treatment course and prognosis for T-cell ...
MCHL is a common type of classic Hodgkin’s lymphoma, most common in people with HIV infection or children with a history of Epstein-Barr virus infection. It has a generally favorable outlook. Mixed ...
Determining the presence of mantle cell lymphoma involves a physical examination, microscopic analysis, genetic screening, and specialized antigen tests. Your body’s lymphatic system is made up of ...
September is Leukemia and Lymphoma Awareness Month. An estimated 1,629,474 people in the United States (US) are living with or in remission from leukemia, lymphoma, myeloma, myelodysplastic syndromes ...
Positron emission tomography (PET) is a type of imaging scan that doctors might use when diagnosing and treating non-Hodgkin’s lymphoma (NHL). It can be useful for identifying and staging the cancer.
Beloved Australian actor, Magda Szubanski, has revealed she's been diagnosed with a "very rare, very aggressive, very serious" blood cancer called mantle cell lymphoma. In a post on social media on ...
Named after the 19th-century scientist who first described abnormal masses in the lymph nodes, Hodgkin lymphoma is a cancer of the lymphatic system. Around 10% of lymphoma diagnoses are categorized as ...
There have been a number of advancements in the treatment of follicular lymphoma in 2024. Additionally, Monjuvi (tafasitamab) has been shown to have positive results regarding disease progression for ...